|
PHF21A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96055999999167E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.817300E-04 |
| Normal-vs-Stage2 |
3.115800E-03 |
| Normal-vs-Stage3 |
1.24720000005407E-06 |
| Normal-vs-Stage4 |
3.91659999999794E-05 |
| Stage1-vs-Stage2 |
8.501800E-01 |
| Stage1-vs-Stage3 |
6.844500E-02 |
| Stage1-vs-Stage4 |
1.719560E-01 |
| Stage2-vs-Stage3 |
2.747200E-01 |
| Stage2-vs-Stage4 |
4.203800E-01 |
| Stage3-vs-Stage4 |
8.192000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68147999999313E-05 |
| Normal-vs-AfricanAmerican |
2.562800E-01 |
| Normal-vs-Asian |
4.483600E-03 |
| Caucasian-vs-AfricanAmerican |
7.405600E-02 |
| Caucasian-vs-Asian |
3.794200E-01 |
| AfricanAmerican-vs-Asian |
2.919000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27250000000012E-05 |
| Normal-vs-Female |
5.93540000000115E-05 |
| Male-vs-Female |
7.025600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.575100E-04 |
| Normal-vs-Age(41-60Yrs) |
6.996000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.62829999997383E-06 |
| Normal-vs-Age(81-100Yrs) |
9.632400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.536600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.423990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.704200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.740610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.208400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.710600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.48239999999634E-05 |
| Classical-VS-Follicular |
3.477800E-01 |
| Classical-VS-Other |
6.346600E-01 |
| Classical-VS-Normal |
2.816900E-04 |
| Tall-VS-Follicular |
1.407930E-02 |
| Tall-VS-Other |
1.689180E-01 |
| Tall-VS-Normal |
1.91119999826128E-08 |
| Follicular-VS-Other |
9.537800E-01 |
| Follicular-VS-Normal |
7.571400E-04 |
| Other-VS-Normal |
7.431800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.27350000000715E-05 |
| Normal-vs-N1 |
3.83160000000382E-05 |
| N0-vs-N1 |
3.508600E-01 |
|
|
